Omnicell, Inc., provides medication management automation solutions and adherence tools for health care systems and pharmacies in the United States and internationally. The company is headquartered in Mountain View, California.
| Revenue (TTM) | $1.23B |
| Gross Profit (TTM) | $537.47M |
| EBITDA | $72.61M |
| Operating Margin | 5.44% |
| Return on Equity | 1.63% |
| Return on Assets | 1.21% |
| Revenue/Share (TTM) | $26.84 |
| Book Value | $27.36 |
| Price-to-Book | 1.56 |
| Price-to-Sales (TTM) | 1.60 |
| EV/Revenue | 1.56 |
| EV/EBITDA | 16.07 |
| Quarterly Earnings Growth (YoY) | -35.90% |
| Quarterly Revenue Growth (YoY) | 14.90% |
| Shares Outstanding | $45.48M |
| Float | $41.81M |
| % Insiders | 2.20% |
| % Institutions | 105.98% |
Volatility is currently expanding